Clinical Practice Guidelines for the Management of Atypical Hemolytic Uremic Syndrome in Korea
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Cheong, Hae Il | - |
dc.contributor.author | Jo, Sang Kyung | - |
dc.contributor.author | Yoon, Sung-Soo | - |
dc.contributor.author | Cho, Heeyeon | - |
dc.contributor.author | Kim, Jin Seok | - |
dc.contributor.author | Kim, Young Ok | - |
dc.contributor.author | Koo, Ja-Ryong | - |
dc.contributor.author | Park, Yong | - |
dc.contributor.author | Park, Young Seo | - |
dc.contributor.author | Shin, Jae Il | - |
dc.contributor.author | Yoo, Kee Hwan | - |
dc.contributor.author | Oh, Doyeun | - |
dc.date.accessioned | 2021-09-03T19:00:51Z | - |
dc.date.available | 2021-09-03T19:00:51Z | - |
dc.date.created | 2021-06-16 | - |
dc.date.issued | 2016-10 | - |
dc.identifier.issn | 1011-8934 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/87245 | - |
dc.description.abstract | Atypical hemolytic uremic syndrome (aHUS) is a rare syndrome characterized by micro-angiopathic hemolytic anemia, thrombocytopenia, and acute kidney injury. The major pathogenesis of aHUS involves dysregulation of the complement system. Eculizumab, which blocks complement C5 activation, has recently been proven as an effective agent. Delayed diagnosis and treatment of aHUS can cause death or end-stage renal disease. Therefore, a diagnosis that differentiates aHUS from other forms of thrombotic microangiopathy is very important for appropriate management. These guidelines aim to offer recommendations for the diagnosis and treatment of patients with aHUS in Korea. The guidelines have largely been adopted from the current guidelines due to the lack of evidence concerning the Korean population. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | KOREAN ACAD MEDICAL SCIENCES | - |
dc.subject | THROMBOTIC THROMBOCYTOPENIC PURPURA | - |
dc.subject | FACTOR-CLEAVING PROTEASE | - |
dc.subject | FACTOR-H-AUTOANTIBODIES | - |
dc.subject | ACUTE KIDNEY INJURY | - |
dc.subject | SHIGA TOXIN | - |
dc.subject | ESCHERICHIA-COLI | - |
dc.subject | COMPLEMENT ACTIVATION | - |
dc.subject | ECULIZUMAB TREATMENT | - |
dc.subject | PLASMA-EXCHANGE | - |
dc.subject | ADULT PATIENTS | - |
dc.title | Clinical Practice Guidelines for the Management of Atypical Hemolytic Uremic Syndrome in Korea | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Jo, Sang Kyung | - |
dc.contributor.affiliatedAuthor | Park, Yong | - |
dc.contributor.affiliatedAuthor | Yoo, Kee Hwan | - |
dc.identifier.doi | 10.3346/jkms.2016.31.10.1516 | - |
dc.identifier.scopusid | 2-s2.0-84983609890 | - |
dc.identifier.wosid | 000381924000005 | - |
dc.identifier.bibliographicCitation | JOURNAL OF KOREAN MEDICAL SCIENCE, v.31, no.10, pp.1516 - 1528 | - |
dc.relation.isPartOf | JOURNAL OF KOREAN MEDICAL SCIENCE | - |
dc.citation.title | JOURNAL OF KOREAN MEDICAL SCIENCE | - |
dc.citation.volume | 31 | - |
dc.citation.number | 10 | - |
dc.citation.startPage | 1516 | - |
dc.citation.endPage | 1528 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART002152324 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | General & Internal Medicine | - |
dc.relation.journalWebOfScienceCategory | Medicine, General & Internal | - |
dc.subject.keywordPlus | THROMBOTIC THROMBOCYTOPENIC PURPURA | - |
dc.subject.keywordPlus | FACTOR-CLEAVING PROTEASE | - |
dc.subject.keywordPlus | FACTOR-H-AUTOANTIBODIES | - |
dc.subject.keywordPlus | ACUTE KIDNEY INJURY | - |
dc.subject.keywordPlus | SHIGA TOXIN | - |
dc.subject.keywordPlus | ESCHERICHIA-COLI | - |
dc.subject.keywordPlus | COMPLEMENT ACTIVATION | - |
dc.subject.keywordPlus | ECULIZUMAB TREATMENT | - |
dc.subject.keywordPlus | PLASMA-EXCHANGE | - |
dc.subject.keywordPlus | ADULT PATIENTS | - |
dc.subject.keywordAuthor | Guidelines | - |
dc.subject.keywordAuthor | Diagnosis | - |
dc.subject.keywordAuthor | Treatment | - |
dc.subject.keywordAuthor | Atypical Hemolytic Uremic Syndrome | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.